Ignite Creation Date:
2024-05-06 @ 2:04 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04205071
Status:
WITHDRAWN
Last Update Posted:
2021-01-19
First Post:
2019-08-05
Brief Title:
Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Ohio State University Comprehensive Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prognostic Stage IV Breast Cancer AJCC v8 |
| Anatomic Stage I Breast Cancer AJCC v8 |
| Anatomic Stage IA Breast Cancer AJCC v8 |
| Anatomic Stage IB Breast Cancer AJCC v8 |
| Anatomic Stage II Breast Cancer AJCC v8 |
| Anatomic Stage IIA Breast Cancer AJCC v8 |
| Anatomic Stage IIB Breast Cancer AJCC v8 |
| Anatomic Stage III Breast Cancer AJCC v8 |
| Anatomic Stage IIIA Breast Cancer AJCC v8 |
| Anatomic Stage IIIB Breast Cancer AJCC v8 |
| Anatomic Stage IIIC Breast Cancer AJCC v8 |
| Anatomic Stage IV Breast Cancer AJCC v8 |
| Chemotherapy-Induced Peripheral Neuropathy |
| Digestive System Carcinoma |
| Prognostic Stage I Breast Cancer AJCC v8 |
| Prognostic Stage IA Breast Cancer AJCC v8 |
| Prognostic Stage IB Breast Cancer AJCC v8 |
| Prognostic Stage II Breast Cancer AJCC v8 |
| Prognostic Stage IIA Breast Cancer AJCC v8 |
| Prognostic Stage IIB Breast Cancer AJCC v8 |
| Prognostic Stage III Breast Cancer AJCC v8 |
| Prognostic Stage IIIA Breast Cancer AJCC v8 |
| Prognostic Stage IIIB Breast Cancer AJCC v8 |
| Prognostic Stage IIIC Breast Cancer AJCC v8 |
Keywords: